First of all, INOL is a development stage pinksheet company.
It's NOT an investment. Neither is it a shortable stock. I don't care what anyone on this board says to the contrary.
It's a trade. Noone knows a thing about this company, the people behind it or the viability of the product to begin to warrant the hype that I'm seeing of people claiming it's going to make everyone filthy stinking rich.
There's nothing different about this company and the way it's going to trade over the next week or two than any other pinky that's traded since the beginning of Pinkydom!
Including the bs that gets spewn as to why "this one is different". LOL
Hey cork! Good to see you over here. Have a starter position with plans to add. If INOL is able to bring this test to market, the legacy revenues could be massive. Every patient in this country who receives a stent during cardiac catheterization is placed on Plavix. As many have mentioned, Plavix is the #2 pharm. drug sold.....period.
128 million O/S with a 50 someodd million float. Very reasonable!
News 
Market Data 
Discover 
AI
